Who owns GYRE?
Institutional ownership of Gyre Therapeutics Inc. from Form 13F, Q2 2026
59 institutional managers reported holding Gyre Therapeutics Inc. (GYRE) in Form 13F filings for Q2 2026, with 4,915,076 shares worth $32.4M. The largest reported holder was BlackRock, Inc. Managers that filed both quarters added a net 1,507,883 shares (+44.3%). 11 opened new positions and 7 sold out.
- Funds holding
- 59
- Value held
- $32.4M
- New / sold out
- 11 / 7
- Net shares, same filers
- +44.3%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of GYRE
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| BlackRock, Inc. | $6.6M | 20.2% | 993,943 | Added |
| Octagon Capital Advisors LP | $6.3M | 19.4% | 954,416 | New |
| Vanguard Capital Management LLC | $5.8M | 17.8% | 876,927 | Trimmed |
| Geode Capital Management, LLC | $3.5M | 10.8% | 532,950 | Added |
| State Street Corp | $1.6M | 5.0% | 245,402 | Added |
| Charles Schwab Investment Management Inc | $1.2M | 3.7% | 184,286 | Added |
| Northern Trust Corp | $1.1M | 3.4% | 169,537 | Added |
| SBI Securities Co., Ltd. | $1.1M | 3.4% | 166,750 | Trimmed |
| Vanguard Fiduciary Trust Co | $996K | 3.1% | 151,073 | Added |
| Vanguard Portfolio Management LLC | $817K | 2.5% | 123,953 | Added |
| Goldman Sachs Group Inc | $568K | 1.8% | 86,235 | Added |
| Bank of New York Mellon Corp | $414K | 1.3% | 62,750 | Added |
| Morgan Stanley | $275K | 0.8% | 41,691 | Added |
| Alliancebernstein L.p. | $171K | 0.5% | 24,590 | Added |
| STRS Ohio | $170K | 0.5% | 25,800 | Added |
| Dimensional Fund Advisors LP | $167K | 0.5% | 25,268 | Unchanged |
| Nuveen, LLC | $161K | 0.5% | 24,505 | New |
| UBS Group AG | $124K | 0.4% | 18,763 | Trimmed |
| Millennium Management LLC | $122K | 0.4% | 18,488 | New |
| Deutsche Bank Ag\ | $118K | 0.4% | 17,939 | Added |
| Rhumbline Advisers | $111K | 0.3% | 16,865 | Added |
| Wells Fargo & Company | $107K | 0.3% | 16,297 | Added |
| Price T Rowe Associates Inc | $100K | 0.3% | 15,031 | New |
| FMR LLC | $99K | 0.3% | 14,974 | Trimmed |
| Royal Bank of Canada | $87K | 0.3% | 13,195 | Added |
Share of 13F holdings is each fund's shares as a share of the 4,915,076 GYRE shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Octagon Capital Advisors LP New+$6.3M
- BlackRock, Inc. Added+$1.6M
- Geode Capital Management, LLC Added+$669K
- Vanguard Portfolio Management LLC Added+$357K
- Northern Trust Corp Added+$235K
- Morgan Stanley Added+$218K
- State Street Corp Added+$192K
- Nuveen, LLC New+$161K
- Bank of New York Mellon Corp Added+$129K
- Charles Schwab Investment Management Inc Added+$126K
Biggest sellers in Q2 2026
- Vanguard Capital Management LLC Trimmed-$707K
- Brevan Howard Capital Management LP Sold out-$96K
- SBI Securities Co., Ltd. Trimmed-$27K
- FMR LLC Trimmed-$25K
- Tower Research Capital LLC (TRC) Trimmed-$22K
- UBS Group AG Trimmed-$15K
- Simplex Trading, LLC Sold out-$5K
- Allworth Financial LP Trimmed-$5K
- California State Teachers Retirement System Trimmed-$3K
- Nisa Investment Advisors, LLC Sold out-$711
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $10.8M and sold $907K; 31 added and 9 trimmed.
Questions about GYRE ownership
- Who owns GYRE stock?
- 59 institutional investment managers reported GYRE positions in their Form 13F filings for Q2 2026, holding 4,915,076 shares worth $32.4M in total. BlackRock, Inc. reported the largest position.
- Are funds buying or selling GYRE?
- In Q2 2026, 11 managers opened new GYRE positions, 31 added, 9 trimmed and 7 sold out. Managers that filed in both quarters added a net 1,507,883 shares.
- How current is this GYRE institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to GYRE by CUSIP. Options are left out. GYRE news and filings · GYRE insider trades · Top funds